| Literature DB >> 19204736 |
Jamie L Brady1, Stuart I Mannering, Svjetlana Kireta, Patrick T Coates, Anna I Proietto, Peter J Cowan, Anthony J F D'Apice, Andrew M Lew.
Abstract
Using heterologous prime-boost (DNA immunization followed by immunization with transfected cells), we have generated depleting mouse anti-baboon CD2 monoclonal antibodies (mAb). These anti-CD2 mAb recognized a diverse range of primate CD2 from New World monkeys and Old World monkeys to humans and have potent immunosuppressive activity for human allo-MLR responses and anti-tetanus-toxoid recall responses. There was no upregulation of activation markers or release of cytokines when the mAb were incubated with human peripheral blood mononuclear cells. Using chimeric NOD-SCID IL2rgamma(null) mice, the mAb were shown to deplete human and cynomolgus monkey T cells in vivo. These anti-CD2 mAb may therefore be important immunological tools in allo- and xenotransplantation.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19204736 DOI: 10.1038/icb.2009.4
Source DB: PubMed Journal: Immunol Cell Biol ISSN: 0818-9641 Impact factor: 5.126